Syra Health to Subcontract for LUKE on a Defense Health Agency contract valued at $43 Billion
Syra Health Corp. (NASDAQ: SYRA) announced that it will subcontract for LUKE on a $43 billion Defense Health Agency (DHA) contract. The 10-year IDIQ contract, running from June 2024 to May 2034, includes staffing services for DHA facilities across the U.S. and its territories. Syra Health will provide medical staffing in various categories, including physicians, nurses, and medical support personnel, to support the MQS2-NG program. Task orders will determine Syra Health's revenue share, with some expected before year-end. This is Syra Health's second federal government contract, following a subcontract with Caduceus Healthcare.
- Syra Health will subcontract on a $43 billion DHA contract, potentially boosting business.
- The 10-year contract ensures long-term engagement and revenue opportunities from June 2024 to May 2034.
- Opportunities for task orders could start generating revenue before the end of the year.
- Increased visibility and recognition through partnership with LUKE and the DHA.
- This is Syra Health's second federal contract, indicating growing credibility in federal healthcare services.
- Revenue share is uncertain and dependent on task orders, creating potential financial unpredictability.
- As a subcontractor, Syra Health may face limitations on contract control and revenue proportion.
- Potential financial risk if task orders are delayed or if fewer orders than expected are received.
- The 10-year contract phase could mean delayed realization of significant revenue.
Insights
Syra Health being selected as a subcontractor for a $43 billion Defense Health Agency contract holds significant financial implications. This subcontract positions the company to gain a share of a substantial federal budget allocation, which could enhance revenue streams over the next decade. However, the allocation of specific task orders will determine the exact financial impact on Syra Health.
Given that this is a 10-year contract, revenue stability and future earnings visibility for Syra Health improve, which might attract long-term investors. The potential volume of work can enhance the company's financial health, allowing it to invest more in innovation and expand its service offerings. However, the dependency on task orders introduces an element of uncertainty in financial planning.
A
The engagement in the Defense Health Agency's program by Syra Health as a subcontractor for LUKE represents a strategic move into the federal healthcare market. This sector is known for its rigorous standards and long-term engagements, which could boost Syra Health's reputation and lead to more federal contracts in the future.
The nature of the contract focuses on providing a comprehensive range of healthcare staffing services, which covers physicians, nurses, dentists and ancillary services. This diversification ensures that Syra Health can leverage its capabilities across different healthcare sectors, thus mitigating the risks associated with dependency on a single type of service.
Furthermore, federal healthcare contracts often entail stringent compliance and quality standards. Successfully executing this contract could bolster Syra Health’s credentials and open doors to similar opportunities. However, the potential benefits come with the challenge of meeting these high standards consistently.
LUKE as part of the unrestricted vendor pool, has been awarded all areas of responsibility for staffing five Defense Health Agency labor markets including physicians, nurses, dentists, ancillary services, and medical support personnel. In support of the contract's execution, Syra Health will serve as a subcontractor for LUKE and help perform the required services including providing contract workers across various healthcare labor categories in support of mission requirements within DHA hospitals, clinics, dental facilities, and health activities in the 50 United States, D.C.,
Task orders – some of which are anticipated to be received before year's end – will determine the portion of contract revenue for Syra Health.
"We are honored to partner with LUKE in support of the Defense Health Agency's needs. Staffing of medical roles to ensure preparedness for those serving our country is vital to our country's health," said Dr. Deepika Vuppalanchi, CEO, Syra Health. "I'm very pleased that Syra Health is being recognized for our commitment to providing exceptional healthcare services to federal agencies."
This is Syra Health's second federal government contract announcement. In addition to operating as a subcontractor for LUKE, Syra Health is also a subcontractor of Caduceus Healthcare.
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company addressing some of healthcare's most significant challenges in areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology solutions. Syra Health's products and services are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and government. For more information, please visit www.syrahealth.com.
FORWARD-LOOKING STATEMENTS
Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the year ended December 31, 2023, and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.
For more information, please contact:
For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health
463-345-5180
christined@syrahealth.com
For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
shamsian@lythampartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-to-subcontract-for-luke-on-a-defense-health-agency-contract-valued-at-43-billion-302144272.html
SOURCE Syra Health
FAQ
What is the value of the Defense Health Agency contract involving Syra Health?
When will Syra Health's subcontract for the DHA contract begin?
What types of services will Syra Health provide under the DHA contract?
How will Syra Health's revenue from the DHA contract be determined?
What is the stock symbol for Syra Health?
